Jami Chrzanowski
Women's Health · Greensboro, NCNPI 1912236126
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,883 of the $27,344 with a category attached, or 80.0%. Organon accounts for 74.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $10,773 and has fallen 90.3% since, to $1,047 in 2025. Among women's health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $117.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$20K
- Merck$3K
- Evofem Biosciences, Inc.$615
- AbbVie$528
- Novo Nordisk$463
- Mayne Pharma Commercial LLC$445
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$21,88380%
- Travel & lodging$9914%
- Food & beverage$4,18715%
- Education$2831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 46 | $20,333 |
| Merck | 5 | $2,896 |
| Evofem Biosciences, Inc. | 47 | $615 |
| AbbVie | 21 | $528 |
| Novo Nordisk | 8 | $463 |
| Mayne Pharma Commercial LLC | 16 | $445 |
| Astellas Pharma US Inc | 15 | $421 |
| Myovant Sciences Inc. | 7 | $248 |
| Amgen | 7 | $215 |
| Lilly USA, LLC | 6 | $187 |
| Bayer | 5 | $159 |
| Shield Therapeutics Inc | 8 | $149 |
| Exeltis, USA Inc. | 8 | $128 |
| Therapeuticsmd, Inc. | 5 | $72 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Avion Pharmaceuticals | 2 | $38 |
| Millicent US Inc | 2 | $33 |
| Urovant Sciences Inc | 2 | $32 |
| Exact Sciences | 2 | $31 |
| Agile Therapeutics, Inc. | 2 | $30 |
| Ascend Therapeutics US, LLC | 1 | $20 |
| Pfizer | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Renovia Inc | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Gilead | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| Cosette Pharmaceuticals Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,344 in reported general payments places this provider in the 95th percentile of 158 women's health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 52 | $4,572 |
| Estradiol (Twice Weekly)Estradiol | 22 | $2,347 |
| ProgesteroneProgesterone, Micronized | 15 | $400 |
| Clobetasol Propionate | 15 | $371 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $226 |
| Fluconazole | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other women's health in Greensboro
- Auma ThongteumGreensboro$654
- Meredith HarrisRaleigh$241K
- Amy KemmerlinCharlotte$8K
- Kylie CajkaCharlotte$5K
- Lindsey MosleyCharlotte$5K
- Lanika WrightGreenville$3K
- Melinda DavesHickory$3K
- Margaret DarstRaleigh$3K
- Kristin AllisonRaleigh$3K
- Tiffany MoonPlymouth$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.